• Aithal, G.P., Day, C.P., Kesteven, P.J.L. & Daly, A.K. (1999) Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications. Lancet, 353, 717719.DOI: 10.1016/s0140-6736(98)04474-2
  • Bach, A.U., Anderson, S.A., Foley, A.L., Williams, E.C. & Suttie, J.W. (1996) Assessment of vitamin K status in human subjects administered “minidose” warfarin. American Journal of Clinical Nutrition, 64, 894902.
  • Booth, S.L. & Suttie, J.W. (1998) Dietary intake and adequacy of vitamin K1. Journal of Nutrition, 128, 785788.
  • Booth, S.L., Sadowski, J.A. & Weihrauch, J.L. (1993) Vitamin K1 (phylloquinone) content of foods: a provisional table. Journal of Food Composition and Analysis, 6, 109120.DOI: 10.1006/jfca.1993.1014
  • Booth, S.L., Sadowski, J.A. & Pennington, J.A.T. (1995) The phylloquinone (vitamin K1) content of foods in the US-FDA Total Diet Study. Journal of Agricultural and Food Chemistry, 43, 15741579.
  • Booth, S.L., Charnley, J.M., Sadowski, J.A., Saltzman, E., Bovill, E.G. & Cushman, M. (1997a) Dietary vitamin K1 and stability of oral anticoagulation: proposal of a diet with constant vitamin K1 content. Thrombosis and Haemostasis, 77, 504509.
  • Booth, S.L., Tucker, K.L., McKeown, N.M., Davidson, K.W., Dallal, G.E. & Sadowski, J.A. (1997b) Relationships between dietary intakes and fasting plasma concentrations of fat-soluble vitamins in humans. Journal of Nutrition, 127, 587592.
  • Davidson, K.W. & Sadowski, J.A. (1997) Determination of vitamin K compounds in plasma or serum by high-performance liquid chromatography using postcolumn chemical reduction and fluorimetric detection. Methods in Enzymology, 282, 408421.
  • Doecke, C.J., Cosh, D.G. & Gallus, A.S. (1991) Standardized initial warfarin treatment: evaluation of initial treatment response and maintenance dose prediction by randomized trial and risk factors for an excessive warfarin response. Australia and New Zealand Journal of Medicine, 21, 319324.
  • Food and Nutrition Board (1989) Recommended Daily Allowances. National Academy of Sciences, Washington, DC.
  • Grosley, B.M., Hirschauer, C., Chambrette, B., Bezaud, A. & Amiral, J. (1996) Specific measurement of hypocarboxylated prothrombin in plasma or serum and application to the diagnosis of hepatocellular carcinoma. Journal of Laboratory and Clinical Medicine, 127, 553564.
  • Gurwitz, J.H., Avorn, J., Ross-Degnan, D., Choodnovsky, I. & Ansell, J. (1992) Aging and the anticoagulant response to warfarin therapy. Annals of Internal Medicine, 116, 901904.
  • James, A.H., Britt, R.P., Raskino, C.L. & Thompson, S.G. (1992) Factors affecting the maintenance dose of warfarin. Journal of Clinical Pathology, 45, 704706.
  • Kamali, F., Edwards, C., Butler, T.J. & Wynne, H.A. (2000) The influence of (R)- and (S) -warfarin, vitamin K and vitamin K epoxide upon warfarin anticoagulation. Thrombosis and Haemostasis, 84, 3942.
  • Lubetsky, A., DekelStern, E., Chetrit, A., Lubin, F. & Halkin, H. (1999) Vitamin K intake and sensitivity to warfarin in patients consuming regular diets. Thrombosis and Haemostasis, 81, 396399.
  • Sorano, G.G., Biondi, G., Conti, M., Mameli, G., Licheri, D. & Marongiu, F. (1993) Controlled vitamin K content diet for improving the management of poorly controlled anticoagulated patients: a clinical practice proposal. Haemostasis, 23, 7782.
  • Taylor, C.T., Chester, E.A., Byrd, D.C. & Stephens, M.A. (1999) Vitamin K to reverse excessive anticoagulation: a review of the literature. Pharmacotherapy, 19, 14151425.